Table 3.

Frequencies of Treg and Th17 Cells in the PB and PF of Women With and Without Endometriosis

ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
Peripheral blood:
 CD4+CD25+FoxP3+
  Treg cells5.5 ± 2.34.8 ± 2.95.2 ± 2.5
  Range in frequency2.2–10.91.0–10.11.2–10.5
 CD4+IL-17A+
  Th17 cells0.5 ± 0.40.5 ± 0.40.3 ± 0.3
  Range in frequency0–1.30–1.30–0.9
Peritoneal fluid:
 CD4+CD25+FoxP3+
  Treg cells7.6 ± 2.86.9 ± 3.311.4 ± 6.8a
  Range in frequency3.2–14.91.4–11.42.6–24.5
 CD4+IL-17A+
  Th17 cells0.4 ± 0.30.7 ± 0.80.7 ± 0.6
  Range in frequency0–0.90.1–2.90–2.3
ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
Peripheral blood:
 CD4+CD25+FoxP3+
  Treg cells5.5 ± 2.34.8 ± 2.95.2 ± 2.5
  Range in frequency2.2–10.91.0–10.11.2–10.5
 CD4+IL-17A+
  Th17 cells0.5 ± 0.40.5 ± 0.40.3 ± 0.3
  Range in frequency0–1.30–1.30–0.9
Peritoneal fluid:
 CD4+CD25+FoxP3+
  Treg cells7.6 ± 2.86.9 ± 3.311.4 ± 6.8a
  Range in frequency3.2–14.91.4–11.42.6–24.5
 CD4+IL-17A+
  Th17 cells0.4 ± 0.30.7 ± 0.80.7 ± 0.6
  Range in frequency0–0.90.1–2.90–2.3

Data given as mean % ± SD.

a

P < 0.05, stage III-IV endometriosis vs stage I-II endometriosis and control group.

Table 3.

Frequencies of Treg and Th17 Cells in the PB and PF of Women With and Without Endometriosis

ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
Peripheral blood:
 CD4+CD25+FoxP3+
  Treg cells5.5 ± 2.34.8 ± 2.95.2 ± 2.5
  Range in frequency2.2–10.91.0–10.11.2–10.5
 CD4+IL-17A+
  Th17 cells0.5 ± 0.40.5 ± 0.40.3 ± 0.3
  Range in frequency0–1.30–1.30–0.9
Peritoneal fluid:
 CD4+CD25+FoxP3+
  Treg cells7.6 ± 2.86.9 ± 3.311.4 ± 6.8a
  Range in frequency3.2–14.91.4–11.42.6–24.5
 CD4+IL-17A+
  Th17 cells0.4 ± 0.30.7 ± 0.80.7 ± 0.6
  Range in frequency0–0.90.1–2.90–2.3
ControlRevised ASRM Stage I-IIRevised ASRM Stage III-IV
Peripheral blood:
 CD4+CD25+FoxP3+
  Treg cells5.5 ± 2.34.8 ± 2.95.2 ± 2.5
  Range in frequency2.2–10.91.0–10.11.2–10.5
 CD4+IL-17A+
  Th17 cells0.5 ± 0.40.5 ± 0.40.3 ± 0.3
  Range in frequency0–1.30–1.30–0.9
Peritoneal fluid:
 CD4+CD25+FoxP3+
  Treg cells7.6 ± 2.86.9 ± 3.311.4 ± 6.8a
  Range in frequency3.2–14.91.4–11.42.6–24.5
 CD4+IL-17A+
  Th17 cells0.4 ± 0.30.7 ± 0.80.7 ± 0.6
  Range in frequency0–0.90.1–2.90–2.3

Data given as mean % ± SD.

a

P < 0.05, stage III-IV endometriosis vs stage I-II endometriosis and control group.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close